SAN DIEGO, CA, November 22, 2021 (GLOBE NEWSWIRE) – via New Media Wire – Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first publicly traded cannabis company in the United States to launch the first cannabis-derived products, brands, and supply chain, today announced that its subsidiary Kannawi® Efforts began to expand its operations into South Africa and Duduzile Mathole was appointed as Country Manager, South Africa.
The cannabidiol (CBD) market in South Africa has witnessed massive growth over the past year as South Africa has scrapped the CBD schedule and made it possible for citizens to purchase CBD products without a prescription in 2020. Recent Reports From the Department of Agriculture, Land Reform and Rural Development, the CBD market in South Africa is currently estimated at around US$1.9 billion and could create more than 25,000 jobs.
Duduzile Mathole brings many years of direct selling experience to the Kannaway® team. Mathole is also well versed in local and regional regulations regarding the cannabis industry throughout South Africa and the continent as a whole.
“I am confident that Duduzile will be a fantastic addition to our team and is more than capable of helping us establish and grow our operations in South Africa and across the region,” said Blake Schroeder, CEO of Kannaway. “We have had great success as a company thus far because of our talented and dedicated team around the world and I know Duduzile will be a great addition to our team. When I joined the company in 2016, I could never have imagined the huge international expansion we have achieved and I am excited about the many new areas that We plan to enter it in the coming years.”
“It is a great honor to join the Kannaway team and to be part of the larger mission that aims to provide the world with free access to quality cannabis products and cannabis education,” said Duduzile Mathole, Director of Kannaway® South Africa. “Together, we can help keep people who want to use cannabis products safely and boost the local economy with new business opportunities.”
To learn more about Kannaway®, please visit the website https://kannaway.com/.
Kannawi® is a network sales and marketing company specializing in the sale and marketing of plant based cannabis products. Currently, Kannaway® hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity for sales professionals who wish to become successful leaders in the sale and marketing of plant-based, hemp-based products.
About Medical Marijuana, Inc.
We are Firsts®. Medical Marijuana, Inc. (MJNA) is a cannabis company comprising three distinct business units in the non-psychoactive cannabis space: a global group of cannabis-based food brands led by Kannawi® And HempMeds®; A leader in sourcing high-quality, legal, non-psychoactive cannabis products derived from industrial hemp; and the sector of cannabis-based clinical research and development of botanical medicines led by pharmaceutical investment firms and partners including AXIM® Biotechnologies, Inc. And Neuropathics. Medical Marijuana, Inc. As the best CBD product ever CNBC. Medical Marijuana, Inc. Also the first company to obtain historical import permits for CBD products from the governments of Brazil, Mexico, Argentina and Paraguay and is a pioneer in developing international markets. The company’s main product Real scientific hemp oil It has been used in several successful clinical studies throughout Mexico and Brazil to understand its safety and efficacy.
Medical Marijuana, Inc. is headquartered in. In San Diego, California, additional information is available at OTCMarkets.com or by visiting www.medicalmarijuanainc.com. To watch a video of Medical Marijuana, Inc. , click here.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the safe harbor law created by those sections. This material contains statements about expected future events and/or financial results of a forward-looking nature and subject to risks and uncertainties. These forward-looking statements by definition include risks, uncertainties and other factors that may cause Medical Marijuana, Inc.’s actual results, performance, or achievements to differ. for the data provided here.
Disclosure by the Food and Drug Administration (FDA)
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Medical Marijuana, Inc. does not. Selling or distributing any products that violate the Controlled Substances Act in the United States.
Investor Relations Contact:
p. (858) 283-4016